068760.KQ Overview

Company Profile

Related stocks

009420.KS • South Korea

HANALL BIOPHARMA

44,000 KRW

1.67B USD 1Y +26.4%

006280.KS • South Korea

GC Biopharma Corp.

129,400 KRW

1.1B USD 1Y -2.2%

195940.KQ • South Korea

HK inno.N

39,700 KRW

839.31M USD 1Y -13.3%

4887.T • Japan

SAWAI GROUP HOLDINGS CO LTD

1,629.5 JPY

1.19B USD 1Y -18.6%

4516.T • Japan

NIPPON SHINYAKU CO

3,372 JPY

1.44B USD 1Y -0.4%

4540.T • Japan

TSUMURA & CO

3,772 JPY

1.78B USD 1Y +5%

2186.HK • China

LUYE PHARMA

1.73 HKD

880.63M USD 1Y -49.7%

6185.HK • China

CANSINOBIO

35.02 HKD

1.1B USD 1Y -28.6%

Key Metrics & Overview

Detailed metrics & financial data of the company

Company Profile

4 Metrics

Country

South Korea

Region

Asia-Pacific

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

🛡️ Risk & Structural Analysis

Multi-Factor Risk Model & Market Data

7/7 Very High

5Y Volatility

47.0% p.a.

Max Drawdown (5Y)

-68.5%

Sharpe Ratio (5Y)

-0.43

Beta Factor

0.90

Size Class

Mega Cap

Notes & Warnings

Single Stock Risk: Investing in an individual stock carries full company and insolvency risk (no fund diversification).

Structurally High Volatility: Above-average fluctuations persist across 5 to 10 years (47.0% p.a.).

Historical Stress Test: Maximum peak-to-trough drawdown of -81.7% in the extended horizon.